At CPHI Milan 2026, Quotient Sciences' Andrew Parker discusses the critical factors that influence bioavailability and formulation success, from solubility and enabling technologies to manufacturability and scale-up.
How AI Is Transforming Bioavailability and Drug Development
The interview by pharmtech.com also explores how artificial intelligence is accelerating formulation development and helping teams optimize drug products more efficiently.
Read the full article on Pharmtech.com website here.